Impact of polymorphisms in apoptosis-related genes on the outcome of childhood acute lymphoblastic leukaemia
Ver/
Fecha
2018-05-29Autor
Cabezas, María
Camos, Mireia
Rives, Susana
Dapena, Josep L.
Caballín, María R.
Armengol, Gemma
Metadatos
Mostrar el registro completo del ítem
British Journal of Haematology 185(1) :159-162 (2019)
Resumen
Despite intensification of therapy, 20% of children with acute lymphoblastic leukaemia (ALL) relapse (Ceppi et al, 2015). The different response to chemotherapy may be partially explained by inherited genetic variants, e.g. single nucleotide polymorphisms (SNPs) and copy number variants (CNVs). However, clinically useful genetic predictors of ALL treatment response are yet to be identified.